Patent Assignment
Reel/Frame 069771/0701
Release of Patent Security Agreements
Recorded: 2024-12-24
Pages: 48
Assignor
MORGAN STANLEY SENIOR FUNDING, INC.
Executed: 2024-12-19
Assignee
ALKERMES PHARMA IRELAND LIMITED
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, D04 C5Y6, IRELAND
Covered Properties
(69)
Prodrugs of Fumarates and Their Use in Treating Various Deseases
PCT:
PCT/US2014/027401 ↗
Aripiprazole Prodrug Compositions
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Pharmaceutical Compositions Having Improved Storage Stability
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
System for Handling Communicated Threats
Application:
15/227,177 →
Publication:
US 2018/0041532
Aripiprazole Formulations Having Increased Injection Speeds
Sulfonamide and Sulfinamide Prodrugs of Fumarates and Their Use in Treating Various Diseases
Methods for Treating Depressive Symptoms
Pharmaceutical Compositions Having Improved Storage Stability
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONIST
Sustained Release Aminopyridine Composition
Application:
15/801,409 →
Publication:
US 2018/0055774
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Methods for Treating Antipsychotic-Induced Weight Gain
Reduction of Flake-Like Aggregation in Nanoparticulate Active Agent Compositions
Process for the Synthesis of Substituted Morphinans
Prodrugs of Nh-Acidic Compounds
Aripiprazole Prodrug Composition
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Electrical Connection Structure Including Tuning Fork-Shaped Terminal
Polymorphic Forms of Naltrexone
Aripiprazole Formulations Having Increased Injection Speeds
Methods for Treating Depressive Symptoms
Sustained Release Aminopyridine Composition
Application:
16/287,575 →
Publication:
US 2019/0231763
Aripiprazole Dosing Strategy
Methods for Treating Antipsychotic-Induced Weight Gain
Compositions of Buprenorphine and µ AntagonistS
Aripiprazole Prodrug Composition
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Pharmaceutical Compositions Having Improved Storage Stability
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Prodrugs of Nh-Acidic Compounds
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Naltrexone Long Acting Formulations and Methods of Use
Application:
16/656,022 →
Morphinan Derivatives with High Oral Bioavailability
Application:
16/739,262 →
Publication:
US 2020/0383970
Polymer-Based Sustained Release Device
Application:
16/749,584 →
Publication:
US 2020/0390891
Morphinan Derivatives for the Treatment of Drug Overdose
Application:
16/784,574 →
Publication:
US 2020/0345718
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Pharmaceutical Compositions Having Improved Storage Stability
Aripiprazole Formulations Having Increased Injection Speeds
Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy
Methods for Treating Antipsychotic-Induced Weight Gain
Aripiprazole Prodrug Composition
Methods for Treating Depressive Symptoms
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Methods for Treating Antipsychotic-Induced Weight Gain
Composition for Treating Mental Illness
Immunomodulatory Il-2 Agents in Combination with Immune Checkpoint Inhibitors
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Il-2 Fusion Polypeptide Compositions and Methods of Making and Using the Same
Application:
17/315,973 →
Publication:
US 2021/0371486
Il-2 Fusion Polypeptide Compositions and Methods of Making and Using the Same
Application:
17/315,974 →
Publication:
US 2021/0395325
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Pharmaceutical Compositions Having Improved Storage Stability
Aripiprazole Prodrug Composition
Application:
17/450,683 →
Publication:
US 2022/0079939
Methods for Treating Antipsychotic-Induced Weight Gain
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy
Immunomodulatory Il-2 Agents in Combination with Immune Checkpoint Inhibitors
Aripiprazole Dosing Strategy
Aripiprazole Formulations Having Increased Injection Speeds
Immediate Release Multilayer Tablet
Immunomodulatory Il-2 Agents in Combination with Immune Checkpoint Inhibitors
Application:
62/916,936 →
Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy
Application:
62/924,356 →
Compositions and Methods for Cancer Immunotherapy
Application:
62/932,160 →
Methods of Purification
Application:
62/965,578 →
Compositions and Methods for Cancer Immunotherapy
Application:
63/309,199 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jun 25, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 033244/0523 →
Assignment of Assignor's Interest
Jul 23, 2015
From: ZEIDAN, TAREK A.; DUNCAN, SCOTT; HENCKEN, CHRISTOPHER P.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 036161/0843 →
Assignment of Assignor's Interest
Oct 14, 2015
From: PERRY, JASON M.; DEAVER, DANIEL R.; HICKEY, MAGALI B.; REMENAR, JULIUS F.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 036790/0263 →
Assignment of Assignor's Interest
Feb 2, 2016
From: CRESSWELL, PHILIP; PAQUETTE, SARA MONTMINY; HICKEY, MAGALI; PERKIN, KRISTOPHER
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 037643/0833 →
Security Interest
May 17, 2016
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 038622/0248 →
Assignment of Assignor's Interest
May 26, 2016
From: MORALES, WILFREDO, JR.; ZEIDAN, TAREK A.; CHIARELLA, RENATO A.; WRIGHT, STEVEN G.
To: ALKERMES, INC.
Reel/Frame 038728/0338 →
Assignment of Assignor's Interest
Aug 3, 2016
From: JOHNSON, JESSICA ANNE
To: ROBLOX CORPORATION
Reel/Frame 039330/0676 →
Assignment of Assignor's Interest
Nov 30, 2016
From: HICKEY, MAGALI B.; VANDIVER, JENNIFER
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 040460/0343 →
Security Interest
Apr 4, 2017
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 041846/0029 →
Assignment of Assignor's Interest
Apr 28, 2017
From: BLUMBERG, LAURA COOK; DEAVER, DANIEL R. R.; EYERMAN, DAVID J.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 042174/0040 →
Corrective Assignment to Correct the Spelling of the Second Assignor Daniel R. Deaver Previously Recorded on Reel 042174 Frame 0040. Assignor(S) Hereby Confirms the Asignment.
May 1, 2017
From: BLUMBERG, LAURA COOK; DEAVER, DANIEL R.; EYERMAN, DAVID J.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 042380/0706 →
Assignment of Assignor's Interest
Jan 23, 2018
From: REMENAR, JULIUS F.; BLUMBERG, LAURA COOK; ZEIDAN, TAREK A.
To: ALKERMES, INC.
Reel/Frame 044698/0678 →
Assignment of Assignor's Interest
Jan 23, 2018
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 044698/0993 →
Assignment of Assignor's Interest
Mar 22, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 045315/0812 →
Corrective Assignment to Correct the Nature of Conveyance from Assignment to Security Agreement Previously Recorded on Reel 045315 Frame 0812. Assignor(S) Hereby Confirms the Security Agreement.
Mar 29, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 045789/0078 →
Assignment of Assignor's Interest
Jun 27, 2018
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 046214/0599 →
Assignment of Assignor's Interest
Nov 9, 2018
From: PERRY, JASON M.; DEAVER, DANIEL R.; HICKEY, MAGALI B.; REMENAR, JULIUS F.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 047461/0093 →
Security Interest
Dec 3, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047661/0244 →
Security Interest
Dec 4, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047671/0386 →
Assignment of Assignor's Interest
Jan 29, 2019
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 048170/0671 →
Assignment of Assignor's Interest
Jan 29, 2019
From: BLUMBERG, LAURA COOK; REMENAR, JULIUS F.; ALMARSSON, ORN; ZEIDAN, TAREK A.
To: ALKERMES, INC.
Reel/Frame 048170/0489 →
Security Interest
Feb 15, 2019
From: ROBLOX CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 048346/0255 →
Security Interest
Mar 20, 2020
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 052914/0832 →
Assignment of Assignor's Interest
Aug 17, 2020
From: CRESSWELL, PHILIP; PAQUETTE, SARA MONTMINY; HICKEY, MAGALI; PERKIN, KRISTOPHER
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 053513/0627 →
Release of Security Interest
Feb 10, 2021
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ROBLOX CORPORATION
Reel/Frame 055221/0252 →